Focusing on the co-expression of FGF19/FGFR4, we compared the patient characteristics between FGF19+FGFR4+ HCC (n = 33) and FGF19−FGFR4− HCC (n = 39) (Fig. 5C). This evidence concerns the gene FGFR4 and hepatocellular carcinoma.